FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, precisely to cellular biology and experimental oncology and can be used for development of new methods aimed at antitumorigenesis. Human chorionic gonadotropin (HCG) is used for stimulation of pathological process and disorganisation of cell carcinoma culture of throat Hep-2.
EFFECT: invention allows effecting turmoral Hep-2 cell lines, excluding lymphocytic mediation, as well as hormone effect through the specific receptors with having signs of tumor degradation in the condition of cell culture.
2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR INHIBITION OF MITOTIC ACTIVITY OF PLISS'S LYMPHOSARCOMA CELLS | 2004 |
|
RU2263514C1 |
| METHOD FOR OBTAINING AUTOLOGOUS REGULATORY T-LYMPHOCYTES BY EX VIVO CULTIVATION IN PRESENCE OF HUMAN CHORIONIC GONADOTROPIN | 2022 |
|
RU2791738C1 |
| METHOD FOR STIMULATING HEPATIC TISSUE REPAIR | 1999 |
|
RU2185835C2 |
| MEDICAL PRODUCT REDUCING CONTENT OF POORLY DIFFERENTIATED CELLS AND INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN NON-SPECIFIC INVASIVE BREAST CARCINOMA | 2019 |
|
RU2743710C1 |
| METHOD OF NEOGENESIS PROCESSES CORRECTION | 2007 |
|
RU2350340C1 |
| AGENT FOR NORMALIZING OF CD4 T-LYMPHOCYTE LEVEL IN PLISS LYMPHOSARCOMA | 2006 |
|
RU2316338C1 |
| AGENT FOR INHIBITION OF PLISS'S LYMPHOSARCOMA GROWTH | 2004 |
|
RU2263513C1 |
| COMPOSITION FOR INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN BREAST ADENOCARCINOMA | 2018 |
|
RU2697199C1 |
| METHOD OF STIMULATION OF HEPATIC TISSUE REGENERATION | 1997 |
|
RU2134582C1 |
| COMPOSITION FOR PREVENTING CHEMORESISTANCE TO ANTIMITOTIC AGENTS | 2022 |
|
RU2807691C1 |
